New DNA test could speed up fungal infection diagnosis in cancer patients
NCT ID NCT03349931
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new DNA test called the MycoGenie kit to see how well it can diagnose invasive aspergillosis, a serious fungal infection, in 350 blood cancer patients. The test looks for the fungus's DNA in blood samples and can also detect drug resistance. The goal is to find a faster, more accurate way to diagnose this infection in high-risk patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE ASPERGILLOSIS IN PATIENTS WITH ONCO-HAEMATOLOGICAL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Lille, Hôpital Claude Huriez
Lille, 59000, France
-
CHU Bordeaux, Groupe hospitalier
Bordeaux, 33000, France
-
CHU de DIJON, Hôpital du bocage
Dijon, 21000, France
-
CHU de Nantes, Hôpital de Moncousu
Nantes, 44000, France
-
CHU de RENNES, hôpital de Pontchaillou
Rennes, 35000, France
-
Hôpital Necker - Enfants maladies (AP-HP)
Paris, Paris, 75015, France